Publication:
Initial Phase 2 Results of Ibrutinib Combined with Bortezomib/Dexamethasone in Previously Treated Patients with Multiple Myeloma

Research Projects

Organizational Units

Journal Issue

Abstract

Description

22nd Congress of the European-Hematology-Association -- JUN 22-25, 2017 -- Madrid, SPAIN

Keywords

Citation

WoS Q

Scopus Q

Source

Volume

102

Issue

Start Page

267

End Page

267

Endorsement

Review

Supplemented By

Referenced By